Slate Path Capital LP

Insider profile

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -106% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Slate Path Capital LP's trades of Cyclerion Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-25 2024-11-21 S Sale
22,322 +18.5%
344.73
US$2,354,993
22,322 +18.5% 344.73 US$2,354,993